These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 947311)

  • 21. Pretreatment with delta 1-tetrahydrocannabinol and psychoactive drugs: effects on uptake of biogenic amines and on behavior.
    Hershkowitz M; Szechtman H
    Eur J Pharmacol; 1979 Nov; 59(3-4):267-76. PubMed ID: 230975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypothermic action of delta 9-tetrahydrocannabinol, 11-hydroxy-delta 9-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice.
    Haavik CO; Hardman HF
    Life Sci; 1973 Dec; 13(12):1771-8. PubMed ID: 4777336
    [No Abstract]   [Full Text] [Related]  

  • 23. Interaction of physostigmine and delta-9-tetrahydrocannabinol in man.
    Freemon FR; Rosenblatt JE; EL-Yousef MK
    Clin Pharmacol Ther; 1975 Feb; 17(2):121-6. PubMed ID: 1091392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative pharmacology of Delta9-tetrahydrocannabinol and its metabolite, 11-OH-Delta9-tetrahydrocannabinol.
    Lemberger L; Martz R; Rodda B; Forney R; Rowe H
    J Clin Invest; 1973 Oct; 52(10):2411-7. PubMed ID: 4729039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The suppressive effect of delta-1-tetrahydrocannabinol on the steroidogenic activity of rat granulosa cells in culture.
    Lewysohn O; Cordova T; Nimrod A; Ayalon D
    Horm Res; 1984; 19(1):43-51. PubMed ID: 6319259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Δ9-tetrahydrocannabinol and its major metabolite Δ9-tetrahydrocannabinol-11-oic acid as 15-lipoxygenase inhibitors.
    Takeda S; Jiang R; Aramaki H; Imoto M; Toda A; Eyanagi R; Amamoto T; Yamamoto I; Watanabe K
    J Pharm Sci; 2011 Mar; 100(3):1206-11. PubMed ID: 20891010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Further in vitro studies on the biochemistry of the inhibition of nucleic acid and protein synthesis induced by arsenic.
    Baron D; Kunick I; Frischmuth I; Petres J
    Arch Dermatol Res (1975); 1975 Aug; 253(1):15-22. PubMed ID: 1190828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain levels of delta1-tetrahydrocannabinol and its metabolites in mice tolerant to the hypothermic effect of delta1-tetrahydrocannabinol.
    Lawrence DK; Pertwee RG
    Br J Pharmacol; 1973 Oct; 49(2):373-5. PubMed ID: 4793443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delta-9-tetrahydrocannabinol-(THC)-mediated inhibition of macrophage macromolecular metabolism is antagonized by human serum proteins and by cell surface proteins.
    Tang JL; Lancz G; Specter S
    Int J Immunopharmacol; 1993 Aug; 15(6):665-72. PubMed ID: 8407051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normal lymphocyte function in the presence of delta-9-tetrahydrocannabinol.
    Rachelefsky GS; Opelz G
    Clin Pharmacol Ther; 1977 Jan; 21(1):44-6. PubMed ID: 137796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of delta-9-tetrahydrocannabinol (cannabis) on cardiac performance with and without beta blockade.
    Kanakis C; Pouget JM; Rosen KM
    Circulation; 1976 Apr; 53(4):703-7. PubMed ID: 1253395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostaglandins and cannabis--XVI. Antagonism of delta 1-tetrahydrocannabinol action by its metabolites.
    Burstein S; Hunter SA; Latham V; Renzulli L
    Biochem Pharmacol; 1986 Aug; 35(15):2553-8. PubMed ID: 3017356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delta-9 tetrahydrocannabinol (THC) inhibits lytic replication of gamma oncogenic herpesviruses in vitro.
    Medveczky MM; Sherwood TA; Klein TW; Friedman H; Medveczky PG
    BMC Med; 2004 Sep; 2():34. PubMed ID: 15369590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo inhibition of enterocyte metabolism by delta 9-tetrahydrocannabinol.
    Desoize B; Nahas GG; Latour C; Vistelle R
    Proc Soc Exp Biol Med; 1986 Apr; 181(4):512-6. PubMed ID: 3006078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-related inhibition of leukocyte migration by marihuana and delta-9-tetrahydrocannabinol (THC) in vitro.
    Schwartzfarb L; Needle M; Chavez-Chase M
    J Clin Pharmacol; 1974 Jan; 14(1):35-41. PubMed ID: 4491907
    [No Abstract]   [Full Text] [Related]  

  • 36. Interactions in man of delta-9-tetrahydrocannabinol. II. Cannabinol and cannabidiol.
    Hollister LE; Gillespie H
    Clin Pharmacol Ther; 1975 Jul; 18(1):80-3. PubMed ID: 1097148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of cannabis.
    Lindgren JE; Ohlsson A; Agurell S; Hollister L; Gillespie H
    Psychopharmacology (Berl); 1981; 74(3):208-12. PubMed ID: 6267648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased unscheduled DNA synthesis in aged human diploid fibroblasts.
    Hasegawa N; Hanaoka F; Yamada M
    Mech Ageing Dev; 1984 Jun; 25(3):297-305. PubMed ID: 6738123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of (-)-delta9-tetrahydrocannabinol on reserpine-induced hypothermia in rats.
    Englert LF; Ho BT; Taylor D
    Br J Pharmacol; 1973 Oct; 49(2):243-52. PubMed ID: 4793331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of delta 9-tetrahydrocannabinol on glucagon receptor coupling to adenylate cyclase in rat liver plasma membranes.
    Hillard CJ; Bloom AS; Houslay MD
    Biochem Pharmacol; 1986 Aug; 35(16):2797-803. PubMed ID: 3017362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.